G325R GBA mutation in Parkinson's disease: Disease course and long-term DBS outcome

G325R GBA mutation in Parkinson's disease: Disease course and long-term DBS outcome

Bibliographic Details
Main Authors:	Claudia Ledda, Carlo Alberto Artusi, Elisa Montanaro, Tiziana Martone, Maurizio Zibetti, Leonardo Lopiano
Format:	Article
Language:	English
Published:	Elsevier 2021-09-01
Series:	Brain Stimulation
Subjects:	GBA G325R Parkinson's disease Deep brain stimulation
Online Access:	http://www.sciencedirect.com/science/article/pii/S1935861X21002047

Similar Items

Should we offer deep brain stimulation to Parkinson’s disease patients with GBA mutations?
by: Carlo Alberto Artusi, et al.
Published: (2023-04-01)

The Consequences of GBA Deficiency in the Autophagy–Lysosome System in Parkinson’s Disease Associated with GBA
by: Eddie Pradas, et al.
Published: (2023-01-01)

Exploring the Genotype–Phenotype Correlation in GBA-Parkinson Disease: Clinical Aspects, Biomarkers, and Potential Modifiers
by: Elisa Menozzi, et al.
Published: (2021-06-01)

The role of dopamine in the pathogenesis of GBA1-linked Parkinson's disease
by: Lena F. Burbulla, et al.
Published: (2019-12-01)

Genetics of Parkinson's disease: Dominant forms and GBA
by: P. Salles, MD, et al.
Published: (2024-07-01)

GBA1 in Parkinson’s disease: variant detection and pathogenicity scoring matters
by: Carolin Gabbert, et al.
Published: (2023-06-01)

Transcriptome deregulation of peripheral monocytes and whole blood in GBA-related Parkinson’s disease
by: Giulietta Maria Riboldi, et al.
Published: (2022-08-01)

Genetic variations in GBA1 and LRRK2 genes: Biochemical and clinical consequences in Parkinson disease
by: Laura J. Smith, et al.
Published: (2022-08-01)

Association of GBA genotype with motor and cognitive decline in Chinese Parkinson’s disease patients
by: Jingru Ren, et al.
Published: (2023-02-01)

Longitudinal evaluation of olfactory function in individuals with Gaucher disease and GBA1 mutation carriers with and without Parkinson's disease
by: Grisel J. Lopez, et al.
Published: (2022-10-01)

Insights into GBA Parkinson's disease pathology and therapy with induced pluripotent stem cell model systems
by: Pascale Baden, et al.
Published: (2019-07-01)

Longitudinal faster anxiety progression of GBA variant carriers in the early Parkinson’s disease cohort
by: Shushan Sang, et al.
Published: (2024-01-01)

Comparative Transcriptome Analysis in Monocyte-Derived Macrophages of Asymptomatic <i>GBA</i> Mutation Carriers and Patients with GBA-Associated Parkinson’s Disease
by: Tatiana Usenko, et al.
Published: (2021-09-01)

α-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism
by: Seung Pil Yun, et al.
Published: (2018-01-01)

Integrated Genetic Analysis of Racial Differences of Common GBA Variants in Parkinson's Disease: A Meta-Analysis
by: Yuan Zhang, et al.
Published: (2018-02-01)

Unraveling neurotransmitter changes in de novo GBA-related and idiopathic Parkinson's disease
by: Jingru Ren, et al.
Published: (2023-09-01)

<i>GBA</i> Variants and Parkinson Disease: Mechanisms and Treatments
by: Laura Smith, et al.
Published: (2022-04-01)

Small Molecule Chaperones for the Treatment of Gaucher Disease and GBA1-Associated Parkinson Disease
by: Tae-Un Han, et al.
Published: (2020-05-01)

Characterization of a pathogenic variant in GBA for Parkinson’s disease with mild cognitive impairment patients
by: Zhiqiang Jiang, et al.
Published: (2020-07-01)

Parkinson’s disease in a patient with GBA and LRRK2 covariants after acute hypoxic insult: a case report
by: Yuting Tang, et al.
Published: (2023-06-01)

Pisa Syndrome in Parkinson's Disease Is Associated With Specific Cognitive Alterations
by: Carlo Alberto Artusi, et al.
Published: (2019-05-01)

Gene Expression of Lysosomal Membrane Proteins in Parkinson Disease, Associated with Mutations in the Glucocerebrosidase Gene (GBA)
by: Tatiana S. Usenko, et al.
Published: (2020-06-01)

GBA-Associated Synucleinopathies: Prime Candidates for Alpha-Synuclein Targeting Compounds
by: Kathrin Brockmann, et al.
Published: (2020-09-01)

GBA Mutations Influence the Release and Pathological Effects of Small Extracellular Vesicles from Fibroblasts of Patients with Parkinson’s Disease
by: Silvia Cerri, et al.
Published: (2021-02-01)

IPSC-Derived Astrocytes Contribute to In Vitro Modeling of Parkinson’s Disease Caused by the <i>GBA1</i> N370S Mutation
by: Elena S. Yarkova, et al.
Published: (2023-12-01)

The Genetic Landscape of Sleep Disorders in Parkinson’s Disease
by: Kallirhoe Kalinderi, et al.
Published: (2024-01-01)

Association Between Glucocerebrosidase Mutations and Parkinson's Disease in Ireland
by: Diana A. Olszewska, et al.
Published: (2020-06-01)

Tuning deep brain stimulation related depression by frequency modulation: A case report
by: Gabriele Imbalzano, et al.
Published: (2020-09-01)

Behavioral Phenotyping in a Murine Model of <i>GBA1</i>-Associated Parkinson Disease
by: Jenny Do, et al.
Published: (2021-06-01)

The Effect of p.G2019S Mutation in the LRRK2 Gene on the Activity of Lysosomal Hydrolases and the Clinical Features of Parkinson's Disease Associated with p.N370S Mutation in the GBA1 Gene
by: Tatiana S. Usenko, et al.
Published: (2024-01-01)

Posterior Cortical Atrophy phenotype in a GBA N370S mutation carrier: a case report
by: Marina Picillo, et al.
Published: (2021-01-01)

Deep Brain Stimulation Selection Criteria for Parkinson’s Disease: Time to Go beyond CAPSIT-PD
by: Carlo Alberto Artusi, et al.
Published: (2020-12-01)

IODP Expedition 325: Great Barrier Reefs Reveals Past Sea-Level, Climate and Environmental Changes Since the Last Ice Age
by: Sally Morgan, et al.
Published: (2011-09-01)

GBA1 variants in Brazilian Gaucher disease patients
by: Suelen Porto Basgalupp, et al.
Published: (2023-12-01)

Parkinson’s Disease-Related Genes and Lipid Alteration
by: Milena Fais, et al.
Published: (2021-07-01)

Secretome Analyses Identify FKBP4 as a <i>GBA1</i>-Associated Protein in CSF and iPS Cells from Parkinson’s Disease Patients with <i>GBA1</i> Mutations
by: Rika Kojima, et al.
Published: (2024-01-01)

The Dominant-STN phenomenon in bilateral STN DBS for Parkinson's disease
by: Anna Castrioto, et al.
Published: (2011-01-01)

A Personalized Approach to Parkinson's disease patients based on founder mutation analysis
by: Nir eGiladi, et al.
Published: (2016-05-01)

Glucocerebrosidase and its relevance to Parkinson disease
by: Jenny Do, et al.
Published: (2019-08-01)

The Role of Rab Proteins in Parkinson’s Disease Synaptopathy
by: Arianna Bellucci, et al.
Published: (2022-08-01)